Physician profile
Weldon Harris
NPI 1548201106
$942.58
in general payments reported to CMS, 2019-2025
18 companies · $69.04 in 2025
The $69.04 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $41.10 · 2021: $143 · 2022: $324 · 2023: $105 · 2024: $21.29 · 2025: $69.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $202.86 | 2021-2023 | Qelbree |
| Cranial Technologies, INC | $127.67 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $115.04 | 2019-2024 | Vaxelis, M-M-R II, Vaxneuvance |
| Sanofi Pasteur INC. | $81.39 | 2019-2022 | |
| Pfizer INC. | $78.21 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $56.64 | 2019-2022 | |
| Rhodes Pharmaceuticals L.P. | $42.28 | 2019 | |
| Glaxosmithkline, LLC. | $37.81 | 2019-2023 | Rotarix, Pediarix, Bexsero |
| Corium, LLC | $33.91 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $32.44 | 2025 | |
| Azurity Pharmaceuticals, INC. | $21.90 | 2025 | Alvesco |
| Genzyme Corporation | $19.39 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.78 | 2019 | |
| Shire North American Group INC | $16.52 | 2019 | |
| Noven Therapeutics, LLC | $15.81 | 2023 | Xelstrym |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $15.45 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $13.75 | 2022 | |
| Neos Therapeutics, Lp | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weldon Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.